SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-001215
Filing Date
2013-01-08
Accepted
2013-01-08 13:40:02
Documents
6
Period of Report
2013-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-2307_18k.htm 8-K 48718
2 EX-4.1 a13-2307_1ex4d1.htm EX-4.1 849408
3 EX-99.1 a13-2307_1ex99d1.htm EX-99.1 29190
4 GRAPHIC g23071mmi001.jpg GRAPHIC 2844
5 GRAPHIC g23071mmi002.jpg GRAPHIC 2948
6 GRAPHIC g23071mmi003.jpg GRAPHIC 1609
  Complete submission text file 0001104659-13-001215.txt   939150
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 13517534
SIC: 2834 Pharmaceutical Preparations